Search This Blog

Monday, February 26, 2024

TransMedics: Stellar Revenue Growth in Q4 and Full Year 2023

 

  • Q4 Revenue: Reached $81.2 million, marking a 159% increase year-over-year.

  • Full Year Revenue: Grew to $241.6 million, also up by 159% from the previous year.

  • Net Income: Achieved $4.0 million in Q4, a significant improvement from a net loss of $6.7 million in Q4 of the prior year.

  • Gross Margin: Reported at 59% in Q4, slightly down from 66% in the same quarter last year.

  • Operating Expenses: Increased to $45.3 million in Q4, driven by investments to support company growth.

  • 2024 Outlook: Anticipates revenue between $360 million to $370 million, representing 49% to 53% growth.

  • Cash Position: Strong with $394.8 million as of December 31, 2023.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.